Baumgart DC et al. |
Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12755840
|
Srinivas NR |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589592
|
BenÃtez C et al. |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. Authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589580
|
Itoh S et al. |
Inhibition of CN (protein phosphatase-2B) suppresses Ca2+-mediated acid secretion in rats. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11966520
|
Yamamoto S et al. |
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18549460
|
O'Leary JG |
Editorial: tacrolimus-how low can you go? |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589579
|
Herrlinger KR et al. |
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20175769
|
Solari S et al. |
Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28261844
|
Högenauer C et al. |
Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12940927
|
Haagsma EB et al. |
Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12848624
|